• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Table 64Patient flow through trials–haloperidol versus asenapine

Intervention #1Intervention #2Intervention #3Intervention #4Intervention #5Intervention #6
Kane et al. 201097ClassificationFGASGASGA
MedicationHaloperidolAsenapineAsenapine
Dosage4mg/d5mg/d10mg/d
No screened:513
No randomized:115114106
No completed:656870
No analyzed (E):112109105
No analyzed (S):115111106

d = day; E = efficacy; FGA = first-generation antipsychotic; mg = milligram; No = number; NR = not reported; S = safety; SGA = second-generation antipsychotic

From: Appendix I, Patient Flow Through Trials

Cover of First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness
First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness [Internet].
Comparative Effectiveness Reviews, No. 63.
Abou-Setta AM, Mousavi SS, Spooner C, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.